Attached files

file filename
EX-32.1 - CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit32ceo.htm
EX-32.2 - CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit32cfo.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit31cfocert.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit31ceocert.htm
EX-10.7.15 - SEPARATION AGREEMENT AND RELEASE - PAR PHARMACEUTICAL COMPANIES, INC.exh10715macpheeseparationand.htm
EX-14 - CODE OF ETHICS - PAR PHARMACEUTICAL COMPANIES, INC.exh14codeofethicsupdatedjuly.htm
EX-10.5.13 - TERMS OF RESTRICTED SHARES AWARD - PAR PHARMACEUTICAL COMPANIES, INC.exh10513termsofrestrictedsha.htm
EX-21 - LIST OF SUBSIDIARIES - PAR PHARMACEUTICAL COMPANIES, INC.exhibit21listofsubsidiariesa.htm
EX-10.5.15 - TERMS OF RESTRICTED STOCK UNIT AWARD - PAR PHARMACEUTICAL COMPANIES, INC.exh10515termsofrestrictedsto.htm
EX-10.5.14 - TERMS OF STOCK OPTION - PAR PHARMACEUTICAL COMPANIES, INC.exh10514termsofstockoption20.htm
EX-10.5.12 - TERMS OF CHIEF EXECUTIVE OFFICER RESTRICTED STOCK UNIT AWARD - PAR PHARMACEUTICAL COMPANIES, INC.exh10512ceorestrictedstockun.htm
10-K - FORM 10K - PAR PHARMACEUTICAL COMPANIES, INC.f201010k22411.htm

EXHIBIT 23

 


 


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in Registration Statement No. 333-160115 on Form S-3 of our reports dated February 24, 2011, relating to the consolidated financial statements of Par Pharmaceutical Companies, Inc. and subsidiaries, and the effectiveness of Par Pharmaceutical Companies, Inc. and subsidiaries internal control over financial reporting appearing in the Annual Report on Form 10-K of Par Pharmaceutical Companies, Inc. and subsidiaries for the year ended December 31, 2010.


/s/ DELOITTE & TOUCHE LLP


New York, New York

February 24, 2011